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Medical management of Gestational Diabetes Mellitus (GDM) has shown that 
lowering blood glucose levels to normoglycemic may help prevent diabetic complications 
for infant and mother.  The objective of this experiment was to determine if consumption 
of carbohydrate, saturated fat, total fat, protein, and fiber affected blood glucose levels in 
pregnant women diagnosed with GDM.  The study included forty-two adult women from 
eight different medical facilities, which included Minnesota, Georgia, Florida, Tennessee, 
and New Mexico.  The women were diagnosed by two abnormal values from an oral 
glucose tolerance test (OGTT) of 100 grams (g).   The additional criteria for inclusion in 
the study were age 18-45 years, carrying a singleton pregnancy, and entry into trial 
between 28 to 32 weeks gestation.  Three-day food records were collected.  Only thirty-
four women had the required data completed for final analysis.  Means and frequencies 
were determined for carbohydrate, protein, total fat, saturated fat, fiber, and calorie intake 
 ii
as well as blood glucose levels at fasting, breakfast, lunch, and supper.  Results showed 
participants in the study had a mean Body Mass Index (BMI) of 29.04 ± 7.27 during the 
time of diagnosis (28 to 32 weeks of pregnancy).  Participants had a mean total caloric 
intake of 1645.04 kilocalories for six meals throughout the day.  Mean total daily intake 
of carbohydrate, protein, fat, saturated fat, and dietary fiber were 188.31 g, 81.62g, 65.09 
g, 22.46 g, and 14.35 g, respectively.  Blood glucose levels for fasting, 1 hour 
postprandial for breakfast, 1 hour postprandial for lunch, and 1 hour postprandial for 
supper were 90.80, 107.38, 109.26, and 109.01 mg/dL, respectively.  Statistical analyses 
performed included three separate regression analyses and Pearson correlations on blood 
glucose level after breakfast, dinner, and supper to different combinations of variables 
that included carbohydrates, total fat, saturated fat, protein, fiber, body mass index, and 
body weight.  Regression analyses indicated that there was a significant negative 
relationship between pregnancy weight and blood glucose levels, one hour after breakfast 
(F= 6.04, Significance= 0.01), however no correlation was found between BMI and blood 
glucose.  The second regression analyses negatively correlated both pregnancy weight 
and BMI to carbohydrate intake at breakfast (F= 2.93, Significance= 0.05).  The final 
regression analyses showed that protein negatively correlated to breakfast blood glucose 
levels (F= 3.2838, Significance= 0.05).  The negative correlation of carbohydrate intake 
as well as the negative correlation of blood glucose levels at breakfast to body weight 
supports the medical nutrition practice of limiting carbohydrate intake at the breakfast 
meal for women with GDM.  This practice of limiting carbohydrate at breakfast was 
further highlighted by the negative correlation of protein to blood glucose.  Thus more 
protein at the breakfast meal decreased blood glucose 1 hour after breakfast.   
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Strategies are required to decrease Gestational Diabetes Mellitus prevalence 
among pregnant women throughout the United States and to help maintain normal blood 
glucose levels.  Targeting all health care professionals to educate women on the 
importance of diet and blood glucose maintain to promote a healthy pregnancy is needed.  
In this study of women with GDM who were followed closely by Registered Dietitians 
showed tight regulation of blood glucose levels is possible.  When carbohydrate intake 
was within recommended levels, no relationship of carbohydrate to blood glucose other 
than the breakfast meal could be identified.   
Research was conducted and funded by the International Diabetes Center, 
Minneapolis, Minnesota.  Analyses and interpretation of data was conducted at the 
University of Wisconsin-Stout.  
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CHAPTER ONE 
 
INTRODUCTION 
 
Introduction 
 
 Gestational Diabetes Mellitus (GDM) is defined as glucose intolerance of variable 
degree with onset or first recognition occurring during pregnancy (Fagen, et al., 1995).  
Factors that can contribute to the risk of developing GDM include obesity, family history 
of diabetes, previous birth of greater than nine pounds, poor obstetrical history, previous 
GDM diagnosis, history of glucose intolerance, history of sugar in the urine, over 25 
years of age, and severe emotional or physical stress (Moses, et al., 1997).  GDM can be 
screened by drawing a 1-hour glucose level following a 50 g glucose load, but is 
definitively diagnosed only by an abnormal 3-hour Oral Glucose Tolerance Test (OGTT) 
following a 100 g glucose load (Fagen, et al., 1995).  GDM is diagnosed during 
pregnancy and in most cases it disappears after birth (Moses, et al., 1997).  GDM usually 
develops because of a faulty physical interaction between the mother and her baby.  
During the second trimester of pregnancy approximately during 24 to 26 weeks gestation, 
the placenta begins producing many hormones.  One of these hormones may block the 
action of insulin causing insulin resistance in the mother.  Since the mother’s insulin isn’t 
as efficient, she now may have difficulty moving sugar out of her blood and into cells and 
if the mother cannot produce enough extra insulin to overcome the resistance, her blood 
sugar will rise.  The high blood sugar stimulates the baby to make more insulin and move 
sugar into the baby’s cells, causing him or her to gain extra weight (macrosomia).  If this 
condition is unregulated, these changes can have serious and harmful effects on both the 
mother and her child (Moses, et al., 1997).   
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 There are many different effects that can harm and cause further complications to 
the baby.  The baby, for instance, may grow very large (macrosomia) which results from 
the increased amounts of sugar the baby is obtaining from the mother’s blood.  Babies 
who are macrosomic can cause a difficult and dangerous delivery.  Another complication 
that the baby can develop is Respiratory Distress Syndrome (RDS), or difficulty 
breathing which is usually due to premature births and underdeveloped lungs.  Other 
complications the baby could develop include jaundice, nervous system conditions, 
weakness, and possible hypoglycemic shock after birth (Moses, et al., 1997).  
 The mother can also be affected by GDM.  One common condition that can affect 
the mother is polyhyramnios or too much amniotic fluid in the uterus.  Polyhyramnios 
can cause the uterus to stretch, which takes up abdominal space and results in difficulty 
breathing (Moses, et al., 1997).  Women with GDM can also develop toxemia (Pregnancy 
Induced Hypertension or PIH), which may result in high blood pressure and swelling 
(Moses, et al., 1997).  Women with GDM may also develop bladder, kidney, and urinary 
tract infections (Moses, et al., 1997).   
Statement of the Problem 
 Medical Management has shown that lowering blood glucose levels to a 
normoglycemic level will help prevent diabetic complications (Fagen, et al., 1995).  
Therefore medical management’s main goal is to prevent perinatal morbidity and 
mortality by normalizing the blood glucose levels to a non-diabetic state.  Dietary and 
Nutritional Therapy is also important in regulating the blood glucose levels in women 
diagnosed with GDM.  Nutritional counseling is the mainstay of therapy for women 
diagnosed with GDM (Fagen, et al., 1995).  The best plan for regulating these blood 
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glucose levels is to provide a diet that contains calories and nutrients necessary for 
maternal and fetal health, which results in normal blood glucose levels, prevents ketosis, 
and results in appropriate weight gain (Fagen, et al., 1995). 
Women with GDM should consume approximately 40-50% carbohydrate, 20-
25% protein, and 30-40% fat during pregnancy (Fagen, et al., 1995).  The recommended 
diet is believed to normalize blood glucose levels while preventing any other metabolic 
abnormalities.  Therefore the purpose of this study was to identify and examine 
carbohydrate, saturated fat, total fat, and fiber consumption that either increases or 
decreases blood glucose levels in pregnant women diagnosed with Gestational Diabetes 
Mellitus.   
Research Objectives 
 The objective of the study is to determine if consumption of carbohydrate, 
protein, saturated fat, total fat, and fiber affect blood glucose levels in pregnant women 
diagnosed with GDM.  The study will help distinguish if these particular macronutrients 
have a positive or a negative effect on blood glucose, which is associated with the 
development and complications associated with GDM.  By obtaining this macronutrient 
information, medical and nutrition professionals can gain greater knowledge pertaining to 
this particular condition. 
Significance of the Study 
 Comparisons can be made to determine if these particular macronutrients and 
their relationship to blood glucose levels promote an increase or decrease in the 
conditions associated with GDM.  Therefore the significance of the study is to provide 
additional information pertaining to GDM regarding blood glucose levels and the 
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consumption of macronutrients (carbohydrates, saturated fat, total fat, and fiber).  The 
study will provide information on the amounts of macronutrients consumed in relation to 
an increase or a decrease in blood glucose levels.  This information can help determine 
whether or not it is safe to consume a certain amount of macronutrients without harming 
the mother or her baby. 
Limitations of the Study   
 The study does not provide information in regards to patients that were eliminated 
from the study because a full three days of food records were missing.  The study does 
not include information in regards to monounsaturated or polyunsaturated fat; 
information regarding fat consumption includes only saturated fat and total fat.  All blood 
glucose levels were self-monitored during the three days by the patients.  This relies on 
accuracy and self-reporting of blood glucose values.  Some of the patients did not record 
all four-blood glucose levels throughout the day; therefore some of the blood glucose 
data is missing.   
Assumptions 
 The first assumption of the study is that carbohydrate consumption to a certain 
degree, usually exceeding 55%, does increase blood glucose levels. 
 The second assumption of the study is that a higher fiber consumption exceeding 
25-35 g decreases blood glucose levels. 
Importance of the Study 
 Four percent of all pregnancies in the US and as many as 14% of minority 
populations are diagnosed with GDM each year.  There is little knowledge about this 
particular disorder; therefore many women go through their pregnancy without proper 
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diagnosis and treatment.  Without proper treatment, medical and physical complications 
can occur.  Thus, it is important to educate and help treat the current disorder to help 
ensure a healthy, normal pregnancy and delivery.  Educating pregnant women on proper 
consumption of nutrients and a healthier lifestyle will help promote a healthy pregnancy 
for both the mother and her baby. 
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CHAPTER TWO  
 
REVIEW OF LITERATURE 
 
 
Introduction 
 
 Gestational Diabetes Mellitus (GDM) also known as hyperglycemia is defined as 
a carbohydrate intolerance of variable severity with the onset or first recognition 
occurring during pregnancy (Fagen, et al., 1995 and Moses, et al., 1997).  During the 
third trimester of pregnancy, the mother experiences an impaired ability to metabolize 
carbohydrates properly.  This factor is usually caused by a deficiency of insulin 
production, which does occur during the third trimester of pregnancy.  Kalhan (1998) 
defined GDM in pregnancy as a disorder of all fuels in the mother wherein decreased 
insulin secretion in the mother results in increased availability or transport to the fetus of 
all insulin-dependent substrates.  Women who are diagnosed with GDM typically have 
normal carbohydrate tolerance before pregnancy, and their carbohydrate tolerance returns 
to normal after delivery as opposed to Diabetes Mellitus Type 1 and Type 2 (Fagen, et. 
al., 1995).  Diabetes Mellitus Type 1 and Type 2 is defined as a lack of insulin secretion 
or a defect in insulin absorption that occurs for a lifetime once diagnosed.   
Epidemiology 
GDM occurs in 2-5% of all pregnancies and is associated with increased maternal 
and fetal-neonatal morbidity and is also a well-known risk factor for metabolic problems 
later on in life (Caruso, et al., 1999).  Tepper and Seldner (1999) stated that GDM affects 
approximately 4% of all pregnancies in the United States and prevalence rates can reach 
as high as 14% in the minority populations.  Jovanovic and Pettitt (2001) stated that 
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GDM can affect up to 14% of the pregnant population, which totals to 135,000 women 
per year in the United States.  Caruso et al. (1999) suggested that the prevalence of GDM 
increases when chronic hypertension is present.  Caruso et al. (1999) also suggested that 
blood pressure influences the degree of insulin resistance in pregnancy and that adiposity 
is a less strong predictor of insulin resistance than a mean arterial pressure in a population 
with normal and abnormal carbohydrate metabolism.  Jovanovic and Pettitt (2001) stated 
that the risk of recurring subsequent pregnancies is reported to be 60%-90%, depending 
on the woman’s first trimester weight in those pregnancies.  Jovanovic and Pettitt (2001) 
also stated that after a pregnancy with GDM, the mother has an increased risk of 
developing type 2 diabetes or impaired glucose tolerance (IGT). 
Fraser (2002) stated that most women experience an increased requirement for 
insulin as pregnancy advances, but this is related to the physiological increase in the 
insulin resistance associated with pregnancy and resolves almost immediately after 
delivery.  Jovanovic and Pettitt (2001) stated that an insulin resistance occurs in some 
degree in all pregnancies, but those women who are unable to compensate develop GDM.   
Butte (2000) stated that by the third trimester, basal glucose concentrations are 
10-15 mg/dL lower and insulin is almost twice the concentration of nongravid women.  
Butte also stated that postprandial glucose concentrations are significantly elevated and 
the glucose peak is prolonged as well as an increase in basal endogenous hepatic glucose 
production to meet the increasing needs of the placenta and fetus.  Butte explained that 
endogenous glucose production remains sensitive to increased insulin concentrations 
throughout gestation, in contrast with the progressive decrease in peripheral insulin 
sensitivity.   
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Butte (2000) stated that during GDM there are alterations in fasting, postprandial, 
and integrated 24-hour plasma concentrations of amino acids, lipids, and glucose and 
there is evidence that supports the view that GDM is related to a pronounced peripheral 
resistance to insulin.  Butte discussed the hormonal changes and differences seen in GDM 
women.  It appears that basal endogenous glucose production increases similarly in 
patients with GDM and in control subjects throughout gestation.  Butte stated that an 
increase in first-phase insulin response was observed in control subjects and in patients 
with GDM with advancing pregnancy; however, the increase is greater in the control 
subjects.  Butte also noted that in late pregnancy, insulin suppression of hepatic glucose 
production is less in patients with GDM.  Butte found that decreased insulin stimulated 
glucose disposal preceded the development of decreased insulin response in women with 
GDM and was evident before pregnancy.  Butte stated that the relative decrease in first-
phase insulin response, as the first manifestation of beta cell dysfunction, and impaired 
suppression of hepatic glucose production becomes evident only after progressive 
decreased insulin sensitivity in late gestation, resulting in hyperglycemia.   
Romon, et al. (2001) have shown that a physiologic increase in plasma free fatty 
acids inhibited insulin-stimulated glucose uptake in healthy pregnant women and 
suggested that the rise in plasma free fatty acids levels observed during late pregnancy 
could at least partly explain insulin resistance seem in GDM.  During pregnancy this may 
be enhanced by the high rate of glucose utilization due to the needs of both fetus and 
placenta.  Therefore the mother will then adapt to an increased demand for glucose by 
increasing gluconeogenesis from glycerol and thus increase lipolysis.  If this condition is 
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not treated properly both the mother and her baby are at risk for serious complications 
(Romon, et al., 2001).   
Complications of Gestational Diabetes Mellitus 
Some of the conditions that have a negative impact on the mother include 
polyhyramnos, premature delivery, pregnancy induced hypertension, and development of 
bladder, kidney, and urinary tract infections.  Polyhyramnos is defined as too much 
amniotic fluid in the uterus which can cause difficulty breathing.  Another condition that 
can be exhibited by untreated GDM is preeclampsia.  Preemclampsia is defined as an 
abnormal condition of pregnancy characterized by the onset of acute hypertension, 
proteinuria, and edema after the twenty-fourth week of gestation (Clausen, et al., 2001).  
Preeclampsia develops as a consequence of a complex interaction among multiplicity of 
factors originating in two genetically different individuals, the mother and the fetus.  
Diagnosis includes requiring the presence of proteinuria and pregnancy-induced 
hypertension.  Preeclampsia if untreated, because of its severity, promotes the risk for an 
increase in premature delivery and prevalence of intrauterine growth retardation.  Not 
only is the mother at risk for complications if GDM goes untreated, the fetus is also at 
risk for complications (Clausen, et al., 2001).   
The risk factor for later onset of Diabetes Mellitus type 2 increases in women 
when GDM is present in pregnancy.  Fraser (2002) stated that the peak incidence of new 
diagnosis of type 2 diabetes occurs after about 20 years of obesity, particularly when 
accompanied by poor nutrition and limited physical activity.  Fraser (2002) examined a 
particular population with an average age of 26 and an average parity of slightly less than 
two.  Fraser concluded that it is therefore likely that if any of these obese, white women 
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chose to have 5 or 6 children and were still reproducing in their late 30’s and early 40’s, 
they would also be a high-risk group for gestationally impaired glucose tolerance (GIGT) 
and GDM.   
Complications to Perinatal Outcomes 
 Negative impacts that affect the fetus include macrosomia, Respiratory Distress 
Syndrome, jaundiced babies, prenatal mortality, neonatal hypoglycemia, polycythemia 
(an increase in the number of erythrocytes in the blood that may be primary or secondary 
to pulmonary disease or heart disease), hypocalcaemia, and hyperbillirubinemia (Fagen, 
et al., 1995 and Tepper and Seldner, 1999).  The most serious complication of undetected 
and untreated GDM is intrauterine fetal demise.  But the most frequent complication of 
GDM is fetal macrosomia (Fagen, et al., 1995).  Macrosomia is defined as an abnormal 
condition characterized by excessive size and stature.  Jovanovic and Pettitt (2001) 
described macrosomia as a birth weight that is either greater than the 90th percentile for 
gestational age and sex or 2 SD’s or more above the normal mean weight.  This may 
affect up to 40% of the offspring of pregnancies complicated with GDM.   
Jovanovic and Pettitt (2001) observed macrosomia in 17.9% of pregnancies 
complicated by GDM despite treatment compared with 5.6% of control subjects.  
Jovanovic and Pettitt stated that macrosomia is associated with an increased risk for birth 
injuries, a direct result of the large size of the fetus.  The risk of shoulder dystocia is 
increased by as much as 30-fold in diabetic pregnancies when the infants weigh more 
than 4500 g.  When estimated fetal weight is excessive, the risk for a cesarean delivery 
increases to avoid shoulder dystocia.  Jovanovic and Pettitt (2001) stated though that 
when the obstetrician delivers the infant early to stop the in utero growth, complications 
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related to prematurity, such as hyperbilirubinemia, hypocalcemia, and respiratory distress 
may result.  Fagen, et al. (1995) suggested that fasting hyperglycemia may be the only 
abnormality of carbohydrate metabolism in obese, pregnant women and this 
hyperglycemia is associated with a 20% increase in the risk of macrosomia.  Macrosomia 
is known as the major perinatal morbidity in GDM and there is a consequential increased 
rate of primary cesarean section (Kalhan 1998 and Gabbe 1998).  The risk of macrosomia 
can be reduced with the use of intensive dietary therapy and glucose monitoring at home, 
which will be discussed later in this review.   
Romon et al. (2001) discussed the relationship of infant birth weight to gestational 
age and the inverse relationship of smoking to birth weight, suggesting that outside 
factors can also contribute to the infant’s state at birth.  Jovanovic and Pettitt (2001) 
stated that another complication associated with GDM is intrauterine growth retardation 
that is associated with subsequent diabetes in populations with a high prevalence of 
malnutrition.   
Infants born of women, who are already diabetic, can also exhibit these 
complications as well as other further complications.  Fraser (2002) stated that 
approximately 30% of apparently well-controlled diabetic women will produce a baby 
who is hyperinsulinaemic and macrosomic.  This would normally be reported as a birth 
weight greater than 4 kg at term or greater than the 90th percentile of weight for 
gestational age.  Fraser also stated that obstetricians and midwives are all well aware that 
maternal diabetes continues to be associated with shoulder dystocia and that this 
complication cannot be competently predicted, therefore it is advised that these women 
with diabetes should not give birth at home, due to these complications.   
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Fraser (2002) stated there are other preexisting complications and malformations 
that occur in infants of diabetic mothers.  These congenital malformations include spina 
bifida, anencephaly (absence of the brain and spinal cord in which the cranium does not 
close and the vertebral canal remains a groove), cardiac anomalies, low gut atresias, renal 
anomalies, situs inversus and caudal regression.   
Long-term Complications upon Neonate 
There are many other factors that not only occur during birth but also affect the 
infant during childhood and adulthood.  Gabbe (1998) discussed that mother’s with GDM 
present during pregnancy increased the likelihood of obesity, glucose tolerance, and 
neurobehavioral and developmental abnormalities at birth and during childhood for their 
infant.  Jovanovic and Pettitt (2001) also stated that the infant of a woman with GDM is 
at a higher risk of developing obesity, impaired glucose tolerance, or diabetes at an early 
age.  Bo et al. (2001) suggested that a possible explanation of the association of shortness 
of stature and GDM could be reduced fetal growth, which was reported to be associated 
with insulin.  Bo et al. further discussed that the prevalent association of short stature 
with GDM in women with a greater mass of fat did support the hypothesis that low birth 
weight predisposes to obesity, reduced height and insulin insensitivity in the adult life.   
Risk Factors for Gestational Diabetes 
When a woman becomes pregnant there are many risks factors she needs to 
examine if there is a concern of GDM being present.  The most common risk factors that 
are associated with GDM include family history of diabetes, obesity, over the age of 30 
years old, personal history of GDM, and belonging to a specific ethnic group.  Jovanovic 
and Pettitt (2001) stated that women at the greatest risk of developing GDM are those 
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who are obese, older than 25 years, have a previous history of abnormal glucose 
metabolism or poor obstetric outcome, have first-degree relatives with diabetes, or are 
members of ethnic groups with high prevalence of diabetes.  Ethnic groups that are 
commonly associated with GDM include Hispanic, African American, Mexican, Native 
American, South or East Asian, and Pacific Island or Indigenous Australian ancestry.     
Caruso et al. (1999) studied the relationship between chronic hypertension and its 
association with GDM.  Caruso et al. discussed that women with GDM have significantly 
higher weight gain during pregnancy but when compared to women with GDM and 
chronic hypertension the weight gain was less than expected.  Caruso et al. showed that 
women with chronic hypertensive GDM had significantly higher systolic, diastolic, and 
mean arterial pressure (MAP) compared with the women with GDM.  Caruso et al. 
reported that chronic hypertensive GDM women had approximately 15% higher body fat 
than women with GDM.  Caruso et al. therefore raised the question as to whether or not 
increased adiposity could account for an increased insulin resistance during pregnancy.  
The study by Caruso et al. suggests that an increase in blood pressure influences the 
degree of insulin resistance in pregnancy and that adiposity is a less strong predictor of 
insulin resistance than MAP in pregnant women with abnormal carbohydrate metabolism.  
Caruso et al. questioned whether there is a possibility that GDM could be a risk factor 
from increased blood pressure and not only an increase in weight.  When discussing 
issues on age and BMI and an increased risk of GDM, Tepper and Seldner’s (1999) study 
demonstrated that women with GDM were older than 27 years of age and had a 
significantly higher prepregnancy BMI than women without GDM.   
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Additional risk factors for GDM that could easily be modified include lack of 
exercise and dietary fat as well as life style habits that adversely influence insulin 
resistance, such as smoking and certain drug use.  Bo et al. (2001) stated that nothing is 
known about the relationship between dietary habits and the impaired glucose 
metabolism in Caucasian women who are pregnant, or whether life style habits cause 
GDM when conventional risk factors for GDM are absent.  Bo et al. also demonstrated 
that GDM patients had higher pre-pregnancy weights and BMI as well as a more frequent 
history of diabetes in first-degree relatives.  The study conducted by Bo et al. also 
demonstrated that the women with GDM had a higher fat intake, especially saturated fat.  
Bo et al. analyzed the data using a multiple regression model using age, lower height, 
familiar diabetes, BMI, and percentages of saturated fat as variables for GDM.  The 
regression model demonstrated that all of these variables were directly associated with 
the presence of GDM after adjusting for gestation age.   
Wang et al. (2000) examined the aspect of increased body weight and the current 
intake of polyunsaturated fat.  Wang et al. demonstrated that both body weight and 
polyunsaturated fat intake showed significant independent relationships with glucose 
concentrations such that increased weight and decreased polyunsaturated fat intake were 
each predictive of the occurrence of GDM.   
The risk factors of GDM can also be associated with a recurrence of GDM from 
previous pregnancies.  Moses et al. (1997) discussed that the recurrence rate of GDM in a 
subsequent pregnancy has ranged from 30-50%.  Factors, which in some studies that have 
been associated with a recurrence of GDM include obesity, weight, gain between 
pregnancies, and insulin use in pregnancy.  While weight gain between pregnancies 
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appears as the most consistent risk associated with a recurrence of GDM, there are no 
reports examining whether any dietary differences exist between women who develop a 
GDM recurrence (Moses, et al., 1997).   
Wang et al. (2000) also demonstrated that variations in the dietary intake of fats 
and carbohydrates can have a profound influence on insulin resistance and sensitivity.  
Wang et al. (2000) concluded that women who developed a recurrence of GDM had a 
significantly higher fat intake than women who did not have a recurrence.  This would 
suggest that a high fat diet, by its effect on insulin resistance, may be linked to the 
development of GDM, and a low fat diet could help protect this condition.   
Physiology of Gestational Diabetes 
During pregnancy, women can experience many different symptoms related to the 
changes occurring in their bodies.  When GDM is present additional symptoms are 
noticed during pregnancy.  One common symptom not necessarily associated with GDM 
but that can contribute to complications is “morning sickness”.  “Morning sickness” 
usually attenuates for the majority of women by week 17, clearly before the diagnosis of 
GDM is made (Fagen, et al., 1995).  However if morning sickness persists throughout the 
third trimester, when GDM is present other complications can exist.  Fagen et al. (1995) 
discussed that ongoing morning sickness could present eating difficulties, especially for 
women who require insulin.  This circumstance may make it very difficult to control 
blood glucose levels, leading to further complications throughout the last trimester of 
pregnancy.   
Another symptom present during GDM is an insulin resistance, especially if there 
is no decompensation in overall glucose and protein turnover during the fasting state.  
 15
Kalhan (1998) discussed that women diagnosed with GDM manifest varying degrees of 
perturbation in protein metabolism.  Kalhan believes that this factor may contribute to 
persistent fetal morbidity in GDM.  Caruso et al. (1999) demonstrated that women with 
pregnancies complicated by concurrent GDM as well as chronic hypertension are greatly 
more resistant to insulin when compared with women with GDM alone, suggesting that 
hypertension has a significant increase in complications related to GDM.   
Another symptom occurring during GDM and pregnancy is the alterations in taste 
perception.  Tepper and Seldner (1999) discussed that taste perception is reduced for 
simple sugars, which could increase the preference for sweet foods in individuals with 
GDM.  As many as 85% of women experience food cravings during pregnancy, which 
are especially acute for sweet foods such as ice cream, cakes, pies, and fruit and fruit 
juices.  Wijendran et al. (1999) defined hyperglycemia and hyperlipidemia; 
predominately elevated VLDL triacylglycerol and increased fatty acids, as common 
symptoms in the third trimester of pregnancies complicated with GDM.   
Fagen et al. (1995) defined that pregnancy is a state of changing hormonal milieu 
that alters maternal metabolism.  Maternal blood glucose levels decrease 0.8 to 1.1 
mmol/L during pregnancy because of the continuous fetal demand, placental glucose 
consumption, and urinary glucose losses.  Fagen et al. (1995) discussed that the second 
half of pregnancy is considered a diabetogenic state because elevated gestational 
hormones and increased maternal weight place a demand on the body for extra insulin.  
Maternal metabolism usually compensates for this altered state by secreting extra insulin.  
Fagen et al. (1995) stated that women with GDM, however, decompensate from a 
euglycemic state to a hyperglycemic state.  Three mechanisms for this decompensation 
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are under study: mutation in the glucokinase gene; insulin resistance related to age, 
obesity, sedentary lifestyle, and family history; and a defect in the adipocyte glucose 
transport system to determine the correct pathophysiology related to this condition.  
Fagen et al. emphasized that carbohydrate, fat, and amino acid metabolism, insulin 
secretion, and insulin sensitivity are all intrinsic abnormalities in the state of GDM.   
Caruso et al. (1999) through previous reports found evidence that, as with Type 2 
Diabetes, women with GDM present with decreased insulin sensitivity, impaired 
suppression of endogenous glucose production by insulin infusion, high levels of 
triglycerides and free fatty acids, and a low high-density lipoprotein (HDL)-to-cholesterol 
ratio.  Caruso et al. (1999) also discussed the similarity between GDM and type 2 
diabetes, both of which are associated with hypertension.   
Fraser (2002) stated that when compared to GDM, the incidence of type 1 
diabetes mellitus is about 1-2 per 1000 mammalian species.  Fraser also stated that 
although there is some evidence of a slight increase in the incidence of type 1 diabetes, 
almost all of the explanations for different prevalence of diabetes between populations 
and ethnic groups are explained by different frequencies of type 2 diabetes mellitus. 
Epidemiologic studies have shown that the incidence of GDM is significantly higher 
among women with chronic hypertension than in the general obstetrics population.  
Caruso et al. (1999) argued that the combination of chronic hypertension and GDM 
represents a more severe metabolic dysfunction than GDM alone.  Wijendran et al. 
(1999) discussed the association between decreased insulin sensitivity combined with 
insufficient insulin secretion in GDM result in exaggerated glucose tolerance and 
alterations in lipid metabolism.  Wijendran et al. also discussed that an insulin resistance 
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coupled with perturbations in general lipid metabolism in GDM may affect essential fatty 
acid metabolism.  This could have important implications for fetal growth and central 
nervous system development.  Hachey (1994) stated that all lipid and lipoprotein 
components of blood are significantly elevated during the third trimester of pregnancy.   
Jovanovic (1999) stated that during GDM as well as diabetes mellitus, cells are 
deprived of glucose in association with a diminished concentration or insufficient action 
of insulin, thereby accelerating ketogenesis.  During pregnancy ketogenesis is especially 
accelerated in the third trimester because of a decline in maternal glucose concentrations 
attributed mainly to fetal glucose utilization, a parallel fall in plasma insulin 
concentrations, and enhanced mobilization of fatty acids caused by the lipolytic 
hormones of pregnancy.   Jovanovic (1999) stated that hyperketonemia in pregnancy has 
been implicated in the pathogenesis of congenital malformations and in mental 
impairment of the offspring of ketogenic mothers.  Studies have observed that plasma 
fatty acid concentrations increased to 50-100% above control values and that plasma 
beta-hydrobutyrate concentrations increased 3-5 fold in both pregnant women with GDM 
and type 1diabetes.   
Screening and Diagnosis 
During pregnancy, all women have to receive a series of tests to help detect any 
complications that can occur.  The American Dietetics Association recommends that all 
pregnant women be screened for GDM between 24 and 28 weeks of gestation (Fagen, et 
al., 1995).  The 1st International Workshop Conference recommended universal 
screening, noting that all pregnant women who had not been identified as having glucose 
tolerance before the 24th week should first have a plasma glucose measurement which is 
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followed by a glucose load for confirmation between the 24th and 28th weeks of gestation 
(Gabbe, 1998).  The standard screening test at present is measurement of plasma glucose 
1 hour after a 50 g glucose load (Fagen, et al., 1995).  Women with glucose levels of 7.8 
mmol/L or more are then given a 100 g glucose load for a 3-hour oral glucose tolerance 
test (Fagen, et al., 1995).  The diagnosis of GDM is made if there are two abnormal 
values on the 100 g oral glucose tolerance test.  Some studies use a higher load of glucose 
for oral tolerance testing.  The conducted study by Moses’s et al. (1997) used a 75 g oral 
glucose tolerance test in the morning after a 12 hour fast at the beginning of their third 
trimester of pregnancy to help detect GDM.  Bo et al. (2001) study as well as other 
studies used specific guidelines when screening for GDM.  Bo et al. study used a 
screening test that was completed in the morning after an overnight fast of at least 8 hours 
but no more than 14 hours and after at least 3 days of an unrestricted diet and exercise.  
Jovanovic and Pettitt (2001) stated that the World Health Organization’s (WHO) criterion 
was based on a glucose load of 75 g.  Jovanovic and Pettitt also stated that with the 
recommendation that the diagnosis of gestational IGT, the physician should be alerted to 
the high-risk nature of the pregnancy, and the gestational IGT should be treated in the 
same way as GDM.   Fraser (2002) stated that the WHO criteria for venous plasma 
glucose diagnosed GDM on a fasting level greater than 7.8 mmol/L and/or a two-hour 
value above 11.1 mmol/L.  Fraser (2002) stated that values in this range can help 
diagnose GDM and decrease the incidence of complications to the mother and the fetus.   
Another way to help detect GDM in the third trimester of pregnancy is to use a 
urea tracer dilution method.  Kalhan’s (1998) study used the urea tracer dilution method 
in overnight fasting subjects and observed a significant decrease in the rate of urea 
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synthesis, which helps detect an increase in protein metabolism during pregnancy.  
Kalhan (1998) also used the Hemoglobin A1c test to help detect GDM in the pregnant 
subjects.  This method of testing helps examine the blood glucose levels over a longer 
period of time than just a few hours.  Gabbe (1998) discussed that the diagnosis of GDM 
would be made when two or more of the following plasma glucose concentrations were 
met or exceeded: fasting, 105 mg/dL; 1-h, 190 mg/dL; 2-h, 165 mg/dL; and 3-h, 145 
mg/dL.  Elevated plasma fasting glucose level of greater than 105 mg/dL was identified 
as increasing the likelihood of poor prenatal outcome.  Gabbe’s (1998) study determined 
though that the cutoff for the screening test of 140 mg/dL (7.8mmol/L) could fail to 
detect approximately 10% of women with GDM.  Gabbe (1998) noted that these 
screening tests need to be more specific in order to make an accurate diagnosis of GDM.   
Glycosuria is another form of screening and diagnosis for GDM during the third 
trimester of pregnancy.  Fraser (2002) stated though that glycosuria becomes an 
unreliable monitoring test in pregnancy because of the low renal threshold for glucose, 
thus not making an accurate GDM diagnosis. 
Medical and Nutrition Therapy 
Once GDM is diagnosed, both medical and nutrition therapy needs to be initiated.  
Proper medical and nutrition management will help reduce problems that are associated 
with GDM.  The main common goal of medical management is to reduce the perinatal 
morbidity and mortality that is associated with GDM through control of maternal blood 
glucose level (Fagen, et al., 1995).  Jovanovic and Pettitt (2001) reported on three studies 
that suggest that the risk of fetal macrosomia increases as the maternal postprandial 
glucose increases.  Jovanovic and Pettitt therefore stated that keeping a 1-hour 
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postprandial blood glucose level between 120 mg/dL and 140 mg/dL minimizes the risk 
of macrosomia.  Jovanovic and Pettitt also stated that although therapy begins with diet, 
insulin therapy should be initiated when peak postprandial response exceeds this target.  
Jovanovic and Pettitt stated that using a continuous glucose monitoring system has 
enabled the detection of previously missed postprandial blood glucose peaks in GDM.  
Jovanovic and Pettitt used this continuous glucose monitoring system in 10 women with 
GDM and discovered that, on average, the women spent 1.8 hours per day with glucose 
concentrations 120 mg/dL or greater.  In these women, the continuous glucose 
monitoring system has revealed high postprandial blood glucose levels, which were 
previously unrecognized by intermittent finger stick evaluation, thus concluding how 
important continuous monitoring during GDM is for both the mother and her fetus.   
Another method of medical management is measuring the HbA1c levels in the 
pregnant women.  The HbA1c test is used to help determine more accurate blood glucose 
levels over a longer period of time, thus establishing whether or not the patient’s blood 
glucose levels indicate GDM.  Fraser (2002) stated that a useful clinical guideline is to 
measure the HbA1c (glycated hemoglobin) in a patient who is planning a pregnancy and 
advise her to continue her usual method of contraception and modify her diabetic control 
until the HbA1c percentage has fallen into the non-diabetic range.   
Nutrition intervention is considered the cornerstone of treatment for all women 
diagnosed with GDM (Fagen, et al., 1995 and Wag, et al., 2000).  To initiate proper 
nutrition management, a registered dietitian assists the patient with GDM to set proper 
goals towards eating healthy and right to help maintain blood glucose levels.  The 
registered dietitian’s most crucial and important goal is achieving normal blood glucose 
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levels while maintaining appropriate nutritional status and adequate dietary intake for 
fetal growth and development.  The Registered Dietitian should then prescribe a meal 
plan that should promote normal blood glucose levels and promote adequate glucose 
monitoring to assess these blood glucose levels.  Fagen et al. (1995) discussed the Sweet 
Success program to help maintain blood glucose levels.  This program recommends 
avoiding fruit juice, processed and refined starch products, and sugar containing 
condiments.  The Sweet Success program recommends a patient should consume three 
meals and three snacks a day and to self monitor glucose levels to normalize blood 
glucose throughout the last half of pregnancy.   
It is also advisable that women measure ketone levels daily to ensure that 
adequate carbohydrate and/or energy are being consumed and to prevent ketosis (Fagen, 
et al., 1995 and Jovanovic, et al., 1999).  The nutrient needs for pregnancy should also be 
met to promote a healthy pregnancy.  Women should be assessed to determine whether or 
not a prenatal multivitamin and mineral should be started to meet any needs that are 
deficient.  Regular exercise sessions should be initiated in order to help regulate blood 
glucose levels.  Fagen et al. (1995) suggested the use of a food diary and blood glucose 
log to help assess the patient’s ability to follow a meal plan and an opportunity to judge 
the effectiveness of the prescribed diet.  Fagen et al. (1995) concluded that nutrition 
education needs to be covered at follow-up visits. Nutrition education should include 
portion sizes, recognizing sugar as an ingredient in prepared food, and eating out 
techniques.  Visual aids such as food models, food labels, recipes, and fast food 
exchanges are also helpful to the learner.   
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Tepper and Seldner (1999) discussed the aspect of low energy diets that have 
been used with some success, but are controversial because of safety concerns for the 
developing infant.  Romon et al. (2001) stated in their study that the first goal of 
management in GDM is to promote optimal growth and development through adequate 
nutrition and avoiding low birth weight or macrosomia.  The second objective discussed 
is to normalize blood glucose levels and the third objective is to prevent excessive weight 
gain in obese women.  Clinical studies have shown that energy restriction in GDM 
associated with obesity controls glycemia and reduces the incidence of macrosomia, but 
severe energy restriction is associated with increased levels of beta-hydroxybutyrate 
(Romon et al., 2001, Hachey, 1994, and Jovanovic and Pettitt, 2001).  Romon et al. 
(2001) stated that in normal pregnant women, high carbohydrate and high fiber diets 
improve glucose homeostasis.  Other studies have suggested that a high fiber diet is 
associated with impaired glucose tolerance during pregnancy.  Romon et al. (2001) 
concluded that a careful distribution of carbohydrates throughout the day and the use of 
low glycemic index foods may help in limiting postprandial hyperglycemia.  Of course, 
energy intake must be adjusted to achieve an appropriate weight gain according to 
prepregnancy BMI.  Wang et al. (2000) stated that short term intervention studies have 
shown improved glucose control on diets emphasizing high monounsaturated fat intake 
compared with a high carbohydrate diet, whereas population based studies have shown 
either neutral or adverse effects of monounsaturated fat intake on measures of insulin 
action and glycemic control.   
If nutrition and diet are unsuccessful during this period, insulin may need to be 
initiated.  Fraser (2002) stated that many women experience an increased requirement for 
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insulin as pregnancy advances, but this is related to the physiological increase in the 
insulin resistance associated with pregnancy and resolves almost immediately after 
delivery.  For those who do need insulin therapy, the type of insulin chosen should be 
based on the specific glucose abnormalities; the frequency of monitoring and the criteria 
for initiation of insulin are controversial.  Jovanovic and Pettitt (2001) stated that a report 
showed that insulin does decrease the incidence of macrosomia, but does not decrease the 
cesarean delivery rate.  Jovanovic and Pettitt also stated that some obstetricians believe 
that women who require insulin therapy are at a higher risk for difficulties during 
delivery, thus criteria for caesarean delivery should be liberalized.  Others have shown 
that decreased incidence of macrosomia decreases the cesarean delivery rate if the 
indications for operative delivery are not changed for the woman with GDM who 
requires insulin.  
Jovanovic and Pettitt (2001) stated that the type of insulin and its dosage schedule 
should be prescribed to lower the baseline and postprandial glucose levels.  The basal 
level need may be given by using an insulin pump or multiple doses of isophane insulin 
(neutral protamine Hagedorn) (NPH).  Jovanovic and Pettitt (2001) stated that the meal 
related hyperglycemia peaks should be treated with rapid acting insulin.  Insulin lispro, 
an analog of human insulin, possesses unique properties that facilitate lowering the 
postprandial glucose concentration and is a valuable therapeutic option in the treatment of 
GDM.  Jovanovic and Pettitt stated that the rapid absorption of insulin lispro allows for a 
faster peak insulin concentration versus regular human insulin.  This effect more closely 
mimics the physiological first-phase insulin release and results in lower postprandial 
glucose concentrations.   
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Fraser (2002) discusses the aspects of insulin therapy not only for the diagnosis of 
GDM, but for diabetes mellitus type 1 and type 2.  Fraser stated that management is very 
similar and indeed in most clinics the women with type 2 diabetes would be switched 
from oral hypoglycemics to insulin for the duration of the pregnancy.  Jovanovic and 
Pettitt (2001) stated that both the American College of Obstetricians and Gynecologists 
and the American Diabetes Association do not recommend the use of oral hypoglycemic 
agents during pregnancy.  More research is needed before the initiation of oral agents can 
be administered during GDM, until then diet therapy and insulin therapy are used to treat 
GDM.  Fraser (2002) stated that insulin treatment requires different regimens, as many of 
these women are obese and very insulin resistant.  Fraser (2002) also stated that 
sometimes these women require four or five times more units of injected insulin per day 
to obtain the same sort of control as a type 1 diabetic.  In the post-natal period where 
breastfeeding has been chosen, the women with diabetes may need fairly intensive 
supervision of her insulin dose.  The requirement for insulin may fall quite dramatically 
on a short-term basis because of the diversion of energy into the process of lactation. 
When looking at proper medical management, exercise is a useful treatment to 
help prevent hyperglycemia and to promote a healthy pregnancy.  Clapp (1998) observed 
that women who continue regular, moderate to high intensity, weight-bearing exercise 
throughout pregnancy deliver lean infants who weigh about 300 g less than controlled 
subjects.  Clapp (1998) concluded that the type of dietary carbohydrate in a healthy, 
physically active woman’s diet influences both her postprandial blood glucose profile and 
her blood sugar response to exercise in both the pregnant and nonpregnant state.   
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Dietary management has been used to treat pregnancies complicated by diabetes 
since the 19th century.  Peterson and Jovanovic-Peterson (1991) have stated that since the 
early years of insulin therapy, the recommended carbohydrate content of the diet has 
steadily risen form 35% of calories to the current recommended level of 50-60% of 
calories.  Peterson and Jovanovic-Peterson stated that dietitians base their guidelines for 
nutritional management on a combination of nutrient requirements in pregnancy 
combined with dietary management of diabetes and self-monitoring of blood glucose.  
Peterson and Jovanovic-Peterson demonstrated that increasing dietary carbohydrates 
from 40-60% resulted in deterioration in glycemic control and a fall in plasma high-
density lipoprotein cholesterol concentrations, but did not lower low-density lipoprotein 
cholesterol concentrations.  Peterson and Jovanovic-Peterson also demonstrated that the 
high monounsaturated fat diet produced better glycemic control than the high 
carbohydrate diet and did not adversely affect plasma lipoprotein.   
When dealing with GDM, there are other management strategies that need to be 
handled, such as obstetric management.  This form of management deals with issues 
related to both the mother and her fetus, which includes proper fetal monitoring, 
intrapartum and postpartum management, Cesarean delivery, breast feeding 
recommendations, weight gain, and monitoring blood glucose levels.  Fagen et al. (1995) 
mentioned two studies that showed an improvement in glycemic response during 
lactation.  In a study of women with recent GDM, the fasting and 2-hour postprandial 
glucose levels improved in lactating women compared with nonlactating women.  In 
addition, high-density lipoprotein levels were noted to be elevated in the lactation group.  
Fagen et al. stated that at 6 to 10 weeks postpartum, a 75 g, 2-hour glucose tolerance test 
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is recommended to detect impaired glucose tolerance or diabetes mellitus.  Fagen et al. 
also stated that lactation lowers fasting concentrations of estradiols, plasma glucose, and 
insulin and may, therefore, mask true glucose intolerance in the lactating state.   
Postpartum care includes education about the increased risk of development of 
diabetes mellitus type 2, the importance of achieving and maintaining desirable body 
weight, and the need for annual glucose tolerance screening (Fagen et al., 1995 and 
Romon et al., 2001).  Counseling should be provided about contraception and the need 
for planning future pregnancies.  Fagen et al. (1995) concluded that continued follow-up 
sessions for evaluation of the women’s food diary, postprandial blood glucose levels, 
weight changes, and results of urine ketone testing are necessary for making adjustments 
to the meal plan to promote a healthy pregnancy and delivery.  Gabbe (1998) stated that it 
is recommended that women with a diagnosis of GDM should be followed postpartum at 
periodic intervals to detect the onset of diabetes early in its course.   
When discussing the consequences and management of GDM, prognosis comes to 
mind.   Prognosis discusses the risk of developing diabetes mellitus type 2, obesity, or 
glucose tolerance in the future for example.  Fagen et al. (1995) discussed the possibility 
that a women diagnosed with GDM in her first trimester may have had undiagnosed non-
insulin diabetes mellitus type 2 before conception and has a higher risk of birth 
abnormalities.  Moses et al. (1997) stated that the recurrence rate of GDM in a 
subsequent pregnancy has ranged from 30 to 50%.  Moses et al. reported that the relative 
risk of developing diabetes mellitus type 2 was increased if the usual diet contained foods 
with a high glycemic index and low fiber content.   
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Macronutrient Content of Diet 
Other studies have shown that long-term ingestion of a high fat diet, particularly 
one containing either an increased amount or a proportion of saturated fats, can be 
associated with insulin resistance and a progression to glucose intolerance and diabetes.  
Gabbe’s (1998) study concluded that it is recommended that women in whom GDM was 
diagnosed should be followed postpartum at periodic intervals to detect the onset of 
diabetes early in its course.  Furthermore, evidence was presented that obesity and 
impaired carbohydrate tolerance may develop in offspring of diabetic mothers (8).  Bo et 
al. (2001) discussed that it has recently been shown that women with recurrent GDM had 
a higher overall intake of fat (as percentage of energy) than those without recurrences. 
Fat consumption and GDM as well as obesity could be very well linked as further 
developing prognosis for diabetes mellitus type 2.   
GDM can be easily prevented if the right goals and habits are set.  Many studies 
have suggested lowering carbohydrates and increasing fat and protein to maintain glucose 
levels, but not enough evidence is available to prove these guidelines.  Other studies 
discuss a decrease in overall energy to help prevent weight gain and maintain blood 
glucose levels to help prevent GDM.  Short-term studies have shown that severe energy 
restriction (50% or 33% energy restriction) improves glucose tolerance but is associated 
with high levels of beta hydroxybutyrate (Romon et al., 2001).  Other studies have 
reported that energy restriction results in decreased maternal weight gain and fewer 
macrosomic infants in obese women with GDM.  However, it has recently been 
demonstrated in pregnant women that a high carbohydrate meal (55 to 60% of energy 
intake) induced no significant change in the glycemic response, if the meal consisted of 
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low glycemic index carbohydrates.  Therefore further research is needed to cover all 
aspects of proper prescribed diet and nutrients recommended during pregnancy.   
Jovanovic and Pettitt (2001) stated that diabetic fetopathy, which is a result of 
maternal postprandial hyperglycemia, can be minimized when the peak postprandial 
response is blunted.  Jovanovic and Pettitt stated that this is best accomplished by 
carbohydrate restriction.  Jovanovic and Pettitt believe that the optimal dietary 
prescription though provides the caloric and nutrient needs to sustain pregnancy but does 
not cause postprandial hyperglycemia.  Jovanovic and Pettitt stated that the American 
Diabetes Association’s diet for nonpregnant persons suggests that meal plans could have 
up to 60% carbohydrate composition. 
  Instituting this high carbohydrate diet for GDM could result in the need for 
insulin therapy in greater than 50% of women.  Jovanovic and Pettitt (2001) stated that 
the National Academy of Sciences concluded that healthy obese pregnant women (greater 
than 150% of ideal body weight) should only gain 6.75 kg; the subsequent infant birth 
weight was optimized if the maternal weight gain was minimized to less than 3 kg or if 
no weight is gained.  Jovanovic and Pettitt compared a study based on a calorie-restricted 
diet in GDM.  The two diets used for this study reported a comparison of a 2400 
kilocalorie diet versus a 1200 kilocalorie diet.  Jovanovic and Pettitt reported that 
ketonemia developed in the calorie-restricted group after one week on the 1200 
kilocalorie per day diet.  Jovanovic and Pettitt also described a 33% carbohydrate 
restricted diet that was studied, resulting in normal range birth weight infants and no 
maternal ketonemia.  Jovanovic and Pettitt also discussed another study where the 
presence of ketouria, which develops in 10% to 20% of all pregnancies after an overnight 
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fast and may protect the fetus from starvation, was seen.  Jovanovic and Pettitt examined 
the two studies and concluded that neonatal complications to maternal ketones were only 
present in mothers with ketonemia from hyperglycemia, not from starvation.  Jovanovic 
and Pettitt concluded by stating that pregnancy is a time when metabolic changes are 
carefully regulated to provide optimum substrate to both mother and fetus, thus subtle 
perturbations in metabolism during pregnancy can have implications not only for the 
mother and fetus but also for future generations. 
Fraser (2002) discussed the issues in regards to pregnant women not only 
diagnosed with GDM, but women who are already diagnosed with diabetes mellitus type 
1 and type 2.  Fraser examined the different aspects of care for these pregnant women to 
provide a healthy pregnancy and birth by initiating proper nutrition.  Fraser stated that the 
primary care team needs to be aware of these cases because of increased risks of 
hyperglycemia secondary to efforts to enhance control, or when nausea and vomiting 
interrupt the normal meal plan.  Fraser stated that diabetic ketoacidosis (DKA) is 
fortunately relatively rare in pregnancy, but it is of considerable importance because it 
can rapidly lead to intrauterine fetal death.  Fraser also stated that diagnostic confusion 
can arise because ketonuria and vomiting are common in pregnancy anyway.  Fraser 
stated that there can also be a group in whom interventions based on lifestyles, 
particularly diet and exercise, might have a major benefit in terms of their long-term 
health and freedom from diabetes and its associated complications.  Fraser therefore 
concluded that throughout pregnancy, but particularly in the peri-conceptional period and 
in the third trimester, outcomes for pregnancy are likely to be optimized by enhanced 
diabetic control.  For example, miscarriage is more common when diabetes is poorly 
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controlled in early pregnancy, but there is no excess of miscarriage in well-controlled 
diabetics.  Fraser stated that similarly, on the basis of a number of quasi-randomized 
studies it is likely that the four to five-fold increases in major congenital malformations 
seen in pregestational diabetes can be reduced by about 70% by enhanced 
periconceptional control. 
There are many other aspects of GDM and macronutrient consumption that can 
help contribute to the treatment and prevention.  Fat intake and GDM has been examined 
in many different studies to look at the overall nutrition aspects of maintaining blood 
glucose levels.  Moses et al. (1997) reported that women who develop a recurrence of 
GDM have a significantly higher fat intake as a percentage of total energy than women 
who did not have a recurrence (Moses et al., 1997 and Bo et al., 2001).  The proportions 
of polyunsaturated, monounsaturated, and saturated fats were the same in both groups in 
a study conducted by Moses et al. (1997) and there were no differences in the dietary 
sources of fat.  Bo et al. (2001) study reported that GDM patients ate a significantly 
higher percentage of saturated fat and a lower intake of polyunsaturated fat.  The 
percentage of saturated fat was an independent predictor of metabolic abnormalities in 
patients and the fact that the few women with an exceptionally high consumption of 
saturated fat all had glucose abnormalities is an intriguing confirmation of this condition.  
According to other literature, a higher proportion of polyunsaturated fat is associated with 
enhanced insulin action.  The findings of Bo et al. (2001) agree with recent data on 
dietary fat subtypes and insulin resistance supporting a link between higher saturated fat 
intake and insulin resistance, progression to glucose intolerance and diabetes.  In fact, a 
high proportion of long chain unsaturated fatty acids and a low proportion of saturated 
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fatty acids in the phospholipids of the skeletal muscle membranes have been related to a 
high insulin sensitivity and seem to affect the glucose stimulated insulin secretion.  Wang 
et al. (2000) concluded that glucose intolerance and GDM were associated as expected 
with increased body weight and BMI, but unexpectedly and independently were 
associated with a reduced intake of polyunsaturated fats.  Wang’s et al. study has shown 
improved glucose control on diets emphasizing high monounsaturated fat intake 
compared with a high carbohydrate diet, whereas population based studies have shown 
either neutral or adverse effects of monounsaturated fat intake on measures of insulin 
action and glycemic control.  Hachey (1994) stated that lowering total fat and cholesterol 
intakes may be possibly an effective means by which to alleviate chronic illnesses.   
To be most effective, the dietary modifications would have to be implemented 
during pregnancy, and the safety and efficacy of the diets would have to be evaluated in 
controlled clinical studies (Hachey, 1994).  In association with this higher percentage of 
fat intake, there was also a proportionate reduction in the amount of carbohydrate and 
fiber eaten (Moses et al., 1997).   
Protein studies have also been examined to determine their role in GDM 
development and treatment.  Kalhan (1998) reported that these studies show that 
pregnancy related nitrogen conservation occurs early in pregnancy and that the down 
regulation of leucine nitrogen turnover observed in normal pregnant women was 
decompensated in the women with GDM.  The rate of leucine nitrogen turnover was 
higher in GDM women than in normal subjects and was similar to that observed in 
nonpregnant subjects.  Thus, both the data reported in the literature and unpublished data 
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suggest significant alterations in maternal protein and amino acid metabolism in GDM 
women.   
Carbohydrate intake has the most controversy and literature available when 
discussing GDM treatment and maintenance.  Romon et al. (2001) reported that the main 
finding in their study was that the macronutrient composition of the diet affects the 
outcome of pregnancy in women with carbohydrate intolerance during pregnancy.  Infant 
birth weight is inversely related to carbohydrate intake.  Fiber intake has also been 
examined and discussed in regards to GDM.  Bo et al. (2001) stated that fiber intake has a 
slight protective role in women with conventional risk factors for GDM.  The diets that 
have been prescribed to lower glucose concentrations may be the same diets that create 
the other metabolic abnormalities associated with GDM (Jovanovic, 1999).   
Jenkins et al. (2000) stated that several epidemiological studies have linked 
consumption of fiber rich foods to a reduced risk of type 2 diabetes mellitus and 
Coronary Heart Disease (CHD).  Jenkins et al. believed that fiber rich foods contain 
different types of fibers as well as other potentially beneficial compounds, and many 
foods naturally high in fiber have a low glycemic index, possibly due to food form.  
Jenkins et al. stated that many beneficial effects seen with pharmacological doses of 
isolated viscous soluble fiber, including insulin sensitivity, decreased LDL cholesterol 
levels, and decreased clotting factors.  Kendall et al. (2002) discussed that the glycemic 
index concept is an extension of the fiber hypothesis, suggesting that fiber consumption 
reduces the rate of nutrient influx in the gut.  Kendall et al. suggested that early studies 
have shown that starchy carbohydrate foods have very different effects on postprandial 
blood glucose and insulin response in healthy diabetic subjects, depending on the rate of 
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digestion.  Kendall et al. further stated that consumption of low glycemic index diets have 
been associated with higher HDL cholesterol concentrations and, in large cohort studies, 
with decreased risk of developing diabetes and cardiovascular disease.  Kendall et al. 
(2002) concluded that despite inconsistencies in the data, sufficient, positive findings 
have emerged to suggest that the dietary glycemic index is of potential importance in the 
treatment and prevention of chronic diseases. 
Effects of Carbohydrate and Fiber on Blood Glucose 
 When dealing with GDM, medical and nutrition therapy is initiated to normalize 
blood glucose levels.  Many studies have suggested decreasing carbohydrate intake or 
increasing fiber intake to treat GDM.  Are these suggestions safe and will they help 
normalize blood glucose levels and treat existing GDM?  
 Butte (2000) stated that studies have shown an increased contribution of 
carbohydrate to oxidative metabolism in late pregnancy.  Butte explained that 
carbohydrate oxidation as a percentage of nonprotein energy expenditure decreases from 
66% to 58% from late pregnancy to six months postpartum.  Butte also stated that 
absolute rates of carbohydrate oxidation are significantly higher in pregnancy than 
postpartum.  Butte suggested that these observations therefore agree with the increased 
glucose production reported in fasted pregnant women, despite lower fasting plasma 
glucose concentration.  The higher respiratory quotient may reflect the obligatory glucose 
use of the fetus, which uses an estimated 20-25 g glucose/d in late gestation, well within 
the increment in carbohydrate oxidation seen in our study.  Butte examined total energy 
expenditure, basal metabolic rate, and whole body net carbohydrate and fat utilization 
and concluded that they did not differ significantly between insulin treated patients with 
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GDM and control subjects.  Butte emphasized that recent findings from the Diabetes in 
Early Pregnancy Trial indicated that the postprandial glucose concentrations, not fasting 
concentrations, are predictive of birth weight.  The American Diabetes Association 
concluded that the percentage of carbohydrate in the diet is dependent on individual 
eating habits and the effect on blood glucose and percentage of body fat depends on 
assessment and treatment goals.  Butte (2000) stated that many studies have shown that 
the lower percentage of carbohydrate blunts the postprandial hyperglycemia.  Butte 
(2000) also noted that one study indicated that carbohydrate restriction improved 
glycemic control, decreased the insulin requirement, decreased the incidence of large for 
gestational age infants, and decreased cesarean deliveries for macrosomia.  However, 
more evidence is needed in order to determine carbohydrate intake and its relationship to 
blood glucose levels.  
 Hallfrisch and Behall (2000) stated that consumption of a number of grains and 
grain extracts has been reported to control or improve glucose tolerance and reduce 
insulin resistance.  Dietary goals recommend the consumption of three or more servings 
per day of whole grains, but the average consumption in the United States is less than one 
serving per day.  Hallfrisch and Behall stated that there are a number of mechanisms by 
which grains may improve glucose metabolism and delay or prevent the progression of 
impaired glucose tolerance to insulin resistance and diabetes.  These mechanisms appear 
to be related to the physical properties and structures of grains.  The composition of the 
grain, including particle size, amount and type of fiber, viscosity, amylose and 
amylopectin content all affect the metabolism of carbohydrates from grains.  Hallfrisch 
and Behall stated that increasing the whole grain intake in the population can result in 
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improved glucose metabolism and delay or reduce the risk of developing type 2 diabetes 
mellitus.  Hallfrisch and Behall also stated that a number of whole grains are beneficial in 
reduction of insulin resistance and improvement in glucose tolerance.  Hallfrisch and 
Behall concluded that recent research using various grains and grain products effective in 
improving insulin resistance or lowering glycemic index is still being studied for further 
information. 
In conclusion, the steps in treatment and prevention of GDM involve detection, 
nutrition counseling and education, and slightly modifying overall daily lifestyle factors.  
This may include changing diet patterns and incorporating exercise into a daily schedule, 
since a moderate part of the pregnant population is not exercising.  Including these steps 
into a women’s lifestyle can significantly play a part in decreasing the risks for both the 
mother with GDM and the baby. 
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CHAPTER THREE 
MATERIALS AND METHODS 
Study Design 
 This study is part of a wider spread prospective study involving the Nutrition 
Practice Guidelines initiated by the American Dietetics Association, conducted from 
February 9, 1999 to the spring of 2001.  The protocol, “Field Test Evaluation of Nutrition 
Practice Guidelines of Gestational Diabetes Mellitus (GDM)”, was reviewed and 
approved by the Protocol Review Committee of the International Diabetes Center 
(Appendix A).  There was Facility Consent form, a Volunteer Dietitian Consent form, 
and a Patient Consent form that were completed at each site (Appendixes B, C, and D).  
Each volunteer dietitian received instructions for obtaining consent, recruitment, 
authorization for release of information by patient, and a summary of the study 
(Appendix E).  Each site had a separate start and end date, with separate IRB approval.  
The study involved nine sites throughout the United States.  The states involved in the 
study included Massachusetts, Iowa, Wisconsin, Texas, Minnesota, Georgia, Florida, 
Tennessee, and New Mexico.  The study involved a total of 42 participants who met the 
established criteria. The patients involved in the study were diagnosed with Gestational 
Diabetes Mellitus (GDM) based upon specific criteria when assessed during their third 
trimester of pregnancy.  In order to determine a diagnosis, the study protocol required 
that the patient had to be diagnosed according to the standards set by their institution at 
approximately 28 weeks gestation, which typically used the 100-gram OGTT (oral 
glucose tolerance test) (at the time of the study, there were 2 sets of blood glucose levels 
used and they did not differentiate). At least 2 of the values from the OGTT needed to be 
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abnormal in order for the women to be diagnosed with GDM (ie fasting: ≥ 105 mg/dL, 1 
hour ≥ 190 mg/dL, 2 hours ≥ 165 mg/dL, 3 hours ≥ 145 mg/dL).  The additional 
eligibility criteria initiated for this study included being in the age range of 18-45 years, 
carrying a singleton pregnancy, and entry into the trial from 28 to 32 weeks gestation.  
Factors that excluded the subjects from the study included already being diagnosed with 
type 1 or type 2 diabetes mellitus, having a diagnosis of sickle cell anemia, thalassemia, 
or other hemoglobinopathy, medical conditions prior to pregnancy (e.g., lupus, 
hypertension, thyroid disease, cardiovascular disease, transplants, renal disease, or other 
serious medical conditions), or being precipitated with current infectious diseases (HIV, 
active TB, or other similar diseases). 
Nutrition Component 
The dietitian spent approximately one hour with each woman to assess and gather 
appropriate data regarding medical history, anthropometric data, laboratory data, lifestyle 
factors, appetite, eating pattern, infant feeding plans, food recall, and exercise.  The 
Dietitian required that the women obtain a three-day food record (Appendix F) in order to 
evaluate their overall diet patterns in regards to carbohydrates, fats, protein, and fiber and 
to compare these nutrients to their self recorded blood glucose levels. 
Once the data were collected and examined, the dietitian was able to provide 
appropriate nutrition counseling and education to the women.  The dietitian provided 
nutrient recommendations, which included sufficient calories to promote adequate weight 
gain, carbohydrate control to ensure maintenance of blood glucose levels, protein needs 
for pregnant women, fat intake, and any other pertinent factors related to nutrition.  
Approximately 40-45% carbohydrate, 20-25% protein, and 30-40% fat was 
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recommended as appropriate intake during this period.  The women were instructed to 
follow a food plan that included 3 small to moderate sized meals and 2-4 snacks per day.  
The meals typically contained 45-60 grams of carbohydrate and 15-30 grams of 
carbohydrate at snacks.  Elimination of foods containing large amounts of carbohydrates 
such as sweets and soft drinks was also recommended at this time to help control blood 
glucose levels.  During the session, the dietitian also instructed the woman on how to 
properly complete a three-day food record by providing examples to help ensure nutrition 
management throughout the remainder of their pregnancy.  Blood glucose levels were 
also monitored and recorded four times a day (fasting, 1 hour postprandial (PP) for 
breakfast, lunch, and supper) by the women to ensure adequate maintenance.  
Maintenance goals for blood glucose levels were defined as 95 mg/dL fasting, less than 
140 mg/dL one hour postprandial, and less than 120 mg/dL two hour postprandial.   
The women were seen later in their pregnancy by the dietitian for a follow-up 
encounter.  The women were instructed to bring a copy of their food and blood glucose 
records for further evaluation. At each follow-up session, the dietitian assessed records of 
food intake, blood glucose testing, weight change, patient’s ability to follow instruction, 
and any questions or concerns needing to be addressed.  The dietitian discussed and 
explained the progression of the therapy during the session to ensure appropriate care 
standards throughout the remainder of the pregnancy.  The women were finally instructed 
to follow their specific food plan and continue to monitor blood glucose levels up until 
delivery. 
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Data Analysis 
 All information was sent and collected by the International Diabetes Center (IDC) 
in Minneapolis, Minnesota for initial examination and evaluation.  Demographic and 
diagnostic information was collected at enrollment of the patients at each facility.  At the 
first initial visit with the Registered Dietitian, Hemoglobin A1c was obtained, and prior 
to delivery at approximately 36-38 weeks gestation.  The food records, which included 
meal pattern and number of meals and snacks consumed were gathered at each individual 
site and then sent to the IDC for further evaluation.  Each Registered Dietitian involved in 
the study, sent a copy of the three-day food records and blood glucose checks to the IDC 
for further data collection.  Once all of the data was gathered by the IDC; total 
carbohydrate, protein, fat, and calories were calculated for examination and analysis.   
 The University of Wisconsin-Stout Institutional Review Board for Protection of 
Human Subjects approved the use of the data.  After all of the pertinent macronutrient 
and non-macronutrient data was collected, data was analyzed using SPSS.  Statistical 
analysis included frequencies, means, standard deviations, maximum, and minimum.  
Regression analysis and Pearson correlation were performed on grams of carbohydrate, 
grams of fiber, grams of protein, grams of total fat, BMI, and pregnancy weight before 
delivery versus blood glucose.  Three separate regression analysis were conducted using 
different variables in the analysis versus blood glucose.  Pearson correlations were 
performed on the variables utilized in the regression analysis. 
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CHAPTER FOUR 
 
RESULTS 
 
 
Calorie Intake 
 
Three-day food records were collected from pregnant women during their third 
trimester of pregnancy, who were diagnosed with Gestational Diabetes Mellitus (GDM).  
Three day means of total calories as well as calories and grams of carbohydrate, protein, 
fat, saturated fat, and fiber for breakfast, am snack, lunch, pm snack, supper, and bedtime 
snack were calculated.  Mean calorie intake is presented in Table 1.  The mean daily 
calorie intake was 1645 kcals (Calories).  Mean caloric distribution between breakfast, 
am snack, lunch, pm snack, supper, and bedtime snack was 301.3 kcals, 128.8 kcals, 
450.2 kcals, 124.2 kcals, 509.3 kcals, and 131.2 kcals, respectively.   
 
Table 1: Three-Day Mean Calorie Intake Obtained between 28-32 Weeks Gestation 
of Pregnant Women with Gestational Diabetes Mellitus 
Meal Time Number  Mean 
(Calories) 
Standard 
Deviation  
Minimum  Maximum 
Breakfast 135   301.27 129.16        0   800.00 
AM Snack 135   128.81 106.02        0   451.20 
Lunch 135   450.23 188.58        0 1253.18 
PM Snack  135   124.21 116.82        0   551.52 
Supper 135   509.31 195.85        0 1061.50 
Bedtime 
Snack  
135   131.24 120.68        0   552.30 
Total  135 1645.04 377.89 652.00 2453.00 
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Macronutrient Distribution 
The three-day mean of macronutrients expressed as a percent of total calories is 
presented in figure 1.  Mean intake of protein, fat, and carbohydrate were 20%, 35%, and 
45% of total calories, respectively.   
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Three-Day Mean Distribution of Macronutrients 
as a Percentage of Total Calories 
 
Figure 1: Mean Distribution of Macronutrients Expressed as Percentage of Total 
Calories Consumed between 28-32 Weeks Gestation by Pregnant Women with 
Gestational Diabetes Mellitus 
 
Carbohydrate Intake 
The carbohydrate intake is presented in Table 2.  The mean daily carbohydrate 
intake was 188.3 g (grams).  This was distributed between breakfast, am snack, lunch, pm 
snack, supper, and bedtime snack as 33.7 g, 19.5 g, 49 g, 19 g, 48.8 g, and 18.3 g, 
respectively.  Figure 2 presents the mean carbohydrate consumed at each meal 
throughout the day expressed as a percentage of total carbohydrate consumed.  This was 
distributed between breakfast, am snack, lunch, pm snack, supper, and bedtime snack as 
18%, 10%, 26%, 10%, 26%, and 10%, respectively.   
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Table 2: Three-Day Mean Carbohydrate Intake Obtained between 28-32 Weeks 
Gestation of Pregnant Women with Gestational Diabetes Mellitus 
Meal Time  Number  Mean 
(Grams) 
Standard 
Deviation  
Minimum  Maximum 
Breakfast  135   33.75 13.98      0   85.35 
AM Snack 135   19.50 15.78      0   69.10 
Lunch 135   48.79 22.10      0 145.19 
PM Snack 135   19.14 16.43      0   66.07 
Supper 135   48.77 24.28      0 135.74 
Bedtime 
Snack 
135   18.36 16.50      0   63.65 
Total 135 188.31 55.49 51.58 342.16 
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Figure 2: Three-Day Mean Distribution of Carbohydrate Intake Consumed (100% 
Carbohydrate Divided throughout the day) between 28-32 Weeks Gestation by 
Pregnant Women with Gestational Diabetes Mellitus. 
 
 
The percentage of energy from carbohydrate for each meal is presented in figure 
3.  The mean daily percentage of carbohydrate was 46% of total calories.  This was 
distributed between breakfast, am snack, lunch, pm snack, supper, and bedtime snack as 
8.2%, 4.5%, 11.9%, 4.6%, 11.9%, and 4.5% of total calories, respectively.  Figure 4 
shows carbohydrate intake at each meal as a percentage of total calories as well as the 
carbohydrate intake at each meal expressed as a percentage of total carbohydrate 
consumed.   
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Figure 3: Three-Day Mean Distribution of Carbohydrate Intake Consumed (45% 
divided throughout the meals) between 28-32 Weeks Gestation by Pregnant Women 
with Gestational Diabetes Mellitus 
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Figure 4: Three-Day Mean Distribution of Carbohydrate Intake at Each Meal 
Expressed as a Percentage of Total Calories and Carbohydrate Intake at Each Meal 
Expressed as a Percentage of Total Carbohydrate Consumed between 28-32 Weeks 
Gestation by Pregnant Women with Gestational Diabetes Mellitus. 
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Protein Intake 
The protein intake is presented in Table 3.  The mean daily protein intake was 82 
g (grams).  This was distributed between breakfast, am snack, lunch, pm snack, supper, 
and bedtime snack as 13.7 g, 4 g, 23 g, 4 g, 31.9 g, and 5 g, respectively.  Figure 5 
presents the mean protein consumed at each meal throughout the day expressed as a 
percentage of total protein consumed.  This was distributed between breakfast, am snack, 
lunch, pm snack, supper, bedtime snack as 17%, 5%, 28%, 5%, 39%, and 6%, 
respectively.   
    
Table 3: Three-Day Mean Protein Intake Obtained between 28-32 Weeks Gestation 
of Pregnant Women with Gestational Diabetes Mellitus  
Meal Time  Number  Mean  
(Grams) 
Standard 
Deviation  
Minimum  Maximum 
Breakfast 135 13.79   7.15      0   35.74 
AM Snack 135   4.03   4.57      0   18.85 
Lunch  135 22.88 13.05      0   73.69 
PM Snack  135   4.02   5.69      0   32.66 
Supper 135 31.90 15.81      0   82.69 
Bedtime 
Snack 
135   5.00   5.58      0   30.28 
Total  135 81.62 24.54 33.91 145.53 
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Three Day Mean Distribution of Protein for Each 
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Figure 5: Three-Day Mean Distribution of Protein Intake Consumed (100% Protein 
Divided throughout the day) between 28-32 Weeks Gestation by Pregnant Women 
with Gestational Diabetes Mellitus. 
 
 
The daily mean of energy from protein divided between meals is presented in 
figure 6.  The three-day mean daily percentage of protein was 20% of total calories.  This 
was distributed between breakfast, am snack, lunch, pm snack, supper, and bedtime snack 
as 3.4%, 0.9%, 5.6%, 0.9%, 7.8%, and 1.2% respectively.  Figure 7 shows protein as a 
percentage of total calories at each meal as well as the protein intake at each meal 
expressed as percentage of total protein consumed. 
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Three Day Mean Distribution of Protein of Each 
Meal Expressed as a Percentage of Total Calories
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Figure 6: Three-Day Mean Distribution of Protein Intake Consumed (20% divided 
throughout the meals) between 28-32 Weeks Gestation Consumed by Pregnant 
Women with Gestational Diabetes Mellitus 
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Figure 7: Three-Day Mean Distribution of Protein Intake at Each Meal Expressed 
as a Percentage of Total Calories and Protein Intake at Each Meal Expressed as a 
Percentage of Total Protein Consumed between 28-32 Weeks Gestation by Pregnant 
Women with Gestational Diabetes Mellitus. 
 
 
 
 47
 
Fat Intake 
 
The fat intake is presented in Table 4.  The mean daily fat intake was 65 g.  This 
was distributed between breakfast, am snack, lunch, pm snack, supper, and bedtime snack 
as 12.7 g, 4.3 g, 18.5 g, 4.2 g, 21 g, and 4.3 g, respectively.  Figure 8 presents the mean 
fat consumed at each meal throughout the day expressed as a percentage of total fat 
consumed.  This was distributed between breakfast, am snack, lunch, pm snack, supper, 
and bedtime snack as 20%, 7%, 28%, 6%, 32%, and 7%, respectively. 
 
Table 4: Three-Day Mean Total Fat Intake Obtained between 28-32 Weeks 
Gestation of Pregnant Women with Gestational Diabetes Mellitus 
Meal Time Number  Mean  
(Grams) 
Standard 
Deviation  
Minimum  Maximum 
Breakfast  135 12.74   8.73      0   48.26 
AM Snack  135   4.28   5.42      0   22.09 
Lunch 135 18.54 11.35      0   60.10 
PM Snack 135   4.19   0.76      0   28.16 
Supper  135 21.01 12.74      0   59.00 
Bedtime 
Snack 
135   4.33   5.70      0   25.26 
Total  135 65.09 23.00 21.58 138.23 
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Three Day Mean Distribution of Fat for Each Meal 
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Figure 8: Three-Day Mean Distribution of Total Fat Intake Consumed (100% Total 
Fat Divided throughout the day) between 28-32 Weeks Gestation by Pregnant 
Women with Gestational Diabetes Mellitus. 
 
 
The daily mean of fat intake as a percentage of total calories that was consumed is 
presented in figure 9.  The three-day mean daily percentage of fat was 35% of total 
calories.  This was distributed between breakfast, am snack, lunch, pm snack, supper, and 
bedtime snack as 7.1%, 2.3%, 10.1%, 2.3%, 11.5%, and 2.3%, respectively.  Figure 10 
shows fat intake at each meal as a percentage of total calories as well as the fat intake at 
each meal expressed as a percentage of total fat consumed.   
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Three Day Mean Distribution of Fat of Each Meal 
Expressed as a Percentage of Total Calories
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Figure 9: Distribution of Fat Intake Consumed (35% divided throughout the meals) 
between 28-32 Weeks Gestation Consumed by Pregnant Women with Gestational 
Diabetes Mellitus 
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Figure 10: Three-Day Mean Distribution of Fat Intake at Each Meal Expressed as a 
Percentage of Total Calories and Fat Intake at Each Meal Expressed as a 
Percentage of Total Fat Consumed between 28-32 Weeks Gestation by Pregnant 
Women with Gestational Diabetes Mellitus. 
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Saturated Fat Intake 
The saturated fat intake is presented in Table 5.  The mean daily saturated fat 
intake was 22.5 g.  This was distributed between breakfast, am snack, lunch, pm snack, 
supper, and bedtime snack as 4.8 g, 1.4 g, 6.3 g, 1.2 g, 6.9 g, and 1.9 g, respectively.  
Figure 11 presents the mean percent of fat consumed at each meal throughout the day 
expressed as a percentage of total calories consumed.  This was distributed between 
breakfast, am snack, lunch, pm snack, supper, and bedtime snack as 22%, 6%, 28%, 5%, 
30%, and 9%, respectively. 
 
Table 5: Three-Day Mean Saturated Fat Intake Obtained between 28-32 Weeks 
Gestation of Pregnant Women with Gestational Diabetes Mellitus 
Meal Time  Number  Mean 
(Grams) 
Standard 
Deviation  
Minimum  Maximum 
Breakfast 135   4.82 3.81     0 26.36 
AM Snack 135   1.38 2.11     0   9.52 
Lunch 135   6.29 4.39     0 21.76 
PM Snack 135   1.20 1.85     0   9.18 
Supper  135   6.87 4.63     0 22.84 
Bedtime 
Snack 
135   1.90 2.73     0 11.77 
Total  135 22.46 9.23 6.12 48.55 
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Three Day Mean Distribution of Saturated Fat for 
Each Meal Expressed as a Percentage of Total 
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Figure 11: Three-Day Mean Distribution of Saturated Fat Intake Consumed (100% 
Saturated Fat Divided throughout the Day) between 28-32 Weeks Gestation by 
Pregnant Women with Gestational Diabetes Mellitus. 
 
 
The percentage of saturated fat intake is presented in figure 12.  The mean daily 
percentage of saturated fat was 12%.  This was distributed between breakfast, am snack, 
lunch, pm snack, supper, and bedtime snack as 12%.  2.6%, 0.8%, 3.4%, 0.7%, 3.8%, and 
1%, respectively.  Figure 13 shows saturated fat intake at each meal as a percentage of 
total calories as well as the saturated fat intake at each meal expressed as a percentage of 
total fat consumed. 
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Figure 12: Three-Day Mean Distribution of Saturated Fat Intake Consumed (12% 
Divided throughout the Meals) between 28-32 Weeks Gestation by Pregnant Women 
with Gestational Diabetes Mellitus 
 
0
5
10
15
20
25
30
35
Br
ea
kfa
st
AM
 Sn
ac
k
Lu
nc
h
PM
 Sn
ac
k
Su
pp
er
Be
dti
me
Breakdown of Saturated Fat
Saturated Fat Expressed as Percentage of Total Calories Per Day
Saturated Fat as Percentage of Total Day
 
Figure 13: Three-Day Mean Distribution of Saturated Fat Intake at Each Meal 
Expressed as a Percentage of Total Calories and Saturated Fat Intake at Each Meal 
Expressed as a Percentage of Saturated Fat Consumed between 28-32 Weeks 
Gestation by Pregnant Women with Gestational Diabetes Mellitus. 
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Fiber Intake 
The fiber intake is presented in table 6.  The mean daily fiber intake was 14.3 g.  
This was distributed between breakfast, am snack, lunch, pm snack, supper, and bedtime 
snack as 2 g, 1.3 g, 4.3 g, 1.5 g, 4.4 g, and 0.8 g, respectively.   
 
Table 6: Three-Day Mean Fiber Intake Obtained between 28-32 Weeks Gestation of 
Pregnant Women with Gestational Diabetes Mellitus 
Meal Time  Number  Mean 
(Grams) 
Standard 
Deviation  
Minimum  Maximum 
Breakfast 135   2.06   1.35     0     7.95 
AM Snack 135   1.33   1.60     0     8.83 
Lunch 135   4.29   3.78     0   17.01 
PM Snack 135   1.50   1.69     0     6.93 
Supper  135   4.39   2.45     0   11.85 
Bedtime 
Snack 
135   0.78   1.22     0     5.96 
Total  135 14.35   5.73 2.99   29.60 
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Blood Glucose Levels 
The blood glucose levels are presented in table 7.  Blood glucose was self-
recorded by the participants at fasting, 1 hour postprandial for breakfast, lunch, and 
supper.  The mean values obtained were 90.8 mg/dL, 107.4 mg/dL, 109.3 mg/dL, and 
109 mg/dL, respectively.  The maximum blood glucose occurred one hour after breakfast 
and the minimum blood glucose occurred one hour after supper. 
 
Table 7: Three-Day Mean Blood Glucose Level Obtained between 28-32 Weeks 
Gestation of Pregnant Women with Gestational Diabetes Mellitus 
Time 
Obtained 
Number  Mean 
(mg/dL) 
Standard 
Deviation  
Minimum  Maximum 
Fasting  107   90.80 13.24 64.00 140.00 
Breakfast (1 
Hour After) 
130  107.38 25.26 65.00 202.00 
Lunch (1 
Hour After) 
121  109.26 24.68 56.00 187.00 
Supper (1 
Hour After) 
124 109.01 21.85 43.00 170.00 
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Regression Analysis 
In a regression analysis using Body Mass Index (BMI) and pregnancy weight 
before delivery versus blood glucose (one hour after breakfast); pregnancy weight 
negatively correlated to glucose one hour after eating breakfast (F= 6.04, Significance= 
0.01) however, BMI did not correlate with blood glucose after breakfast.  The negative 
correlation of pregnancy body weight to blood glucose is plotted in Figure 14.  However, 
neither BMI nor pregnancy weight before delivery correlated to blood glucose one hour 
after lunch or one hour after supper.  Pregnancy Body Weight is presented in Figure 14. 
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Figure 14: Blood Glucose Recorded One-Hour After Breakfast Plotted Against 
Pregnancy Body Weight. 
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A second regression analysis was also performed using pregnancy weight before 
delivery, carbohydrate grams, grams of fiber, and BMI versus blood glucose one hour 
after breakfast.  Pregnancy weight negatively correlated to grams of carbohydrate 
consumed at breakfast.  Figure 15 shows the plot of the negative correlation of pregnancy 
weight versus grams of carbohydrate.  Similar to pregnancy weight, BMI was also 
negatively correlated to grams of carbohydrate consumed at breakfast (F= 2.93, 
Significance= 0.05).  Grams of fiber did not correlate to blood glucose (one hour after 
breakfast).  None of the variables, BMI, pregnancy weight before delivery, carbohydrate 
grams, or grams of fiber correlated to blood glucose one hour after lunch or one hour 
after supper. 
 
Three-Day Mean Carbohydrate Consumed at 
Breakfast Plotted Against Pregnancy Body Weight
0
10
20
30
40
50
60
0 20 40 60 80 100 120 140
Pregnancy Body Weight (Kg)
C
ar
bo
hy
dr
at
e 
(g
ra
m
s)
 
Figure 15: Three-Day Mean Distribution of Grams of Carbohydrate Consumed at   
Breakfast Plotted Against Pregnancy Body Weight. 
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In another regression analysis comparing protein, fat, BMI, and pregnancy weight 
before delivery versus blood glucose, only protein negatively correlated to blood glucose 
at breakfast (F= 3.2838, Significance= 0.05).  There were no correlations of any of these 
variables to blood glucose one hour after the lunch or supper meals. 
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CHAPTER FIVE 
 
DISCUSSION 
 
 
 This study is part of a wider spread prospective study involving the Nutrition 
Practice Guidelines initiated by the American Dietetics Association, conducted from 
February 9, 1999 to the spring of 2001.  Three-day food records and blood glucose values 
for four time periods were recorded and obtained by pregnant women during their third 
trimester of pregnancy who were diagnosed with Gestational Diabetes Mellitus (GDM).  
The results collected included total calories, carbohydrate, protein, fat, saturated fat, 
fiber, and blood glucose levels- fasting; breakfast, 1 hour postprandial; lunch, 1 hour 
postprandial; and supper, 1 hour postprandial.  The results were later complied and 
analyzed at the University of Wisconsin-Stout using SPSS.   
Kilocalorie Intake 
Kilocalories (kcals) ranged from 652 to 2453 per day with a mean value of 1645 
kcals.  The current recommendations for pregnant women with Gestational Diabetes 
Mellitus (GDM) is between 1700-1800 kcals per day to gain appropriate weight during 
the final trimester and to also prevent ketoacidosis (American Dietetic Association, 
2001).  Twenty-six out of thirty-five participants included in this study obtained less than 
the recommended intake of 1700-1800 kcals per day.  The mean weights ranged from 54 
kilograms (kg) to 125 kg with a mean value of 79 kg.  The mean body mass index ranged 
from 19 to 48 with a mean value of 29.  The current standard for normal non-pregnant 
BMI is between 19.8 and 26.0.  There were 19 out of 35 participants included in this 
study who had a BMI outside the current standard normal range.   
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Macronutrient Content 
 Mean macronutrient content expressed as a percentage of total calories was 45%, 
20%, and 35% for carbohydrate, protein, and fat, respectively.  The current 
recommendations for macronutrient content for pregnant women with GDM is 40-45%, 
20-25%, and 30-35% for carbohydrate, protein, and fat, respectively (American Dietetic 
Association, 2001).  Therefore the mean intake of all macronutrients fell within these 
ranges. 
Carbohydrate Content 
 Total carbohydrate content of diet ranged from 51 g to 342 g total per day with a 
mean value of 188 g.  It is recommended that women consume at least 100 g of 
carbohydrate throughout the day to prevent ketosis from occurring.  A total of 94% of 
pregnant women in this study met the recommended amount for preventing ketosis, while 
6% of the women did not.  A lower intake of 15-30 g of carbohydrate is recommended at 
breakfast for women with GDM due to a lower tolerance during pregnancy and abnormal 
hormonal balance causing an increase in blood glucose levels in the morning (American 
Dietetic Association, 2001).  The largest intake of carbohydrate as total kcals was at 
lunch and supper.  The smallest intake of carbohydrate as total kcals was at breakfast.  
The results of the study showed that the participants indeed were following the current 
recommendations.  According to the Food and Nutrition Board, the recommendation for 
carbohydrate during an uncomplicated pregnancy is 45-65% or 175 g per day (National 
Academy of Sciences, 2002). Based on this finding, 60% consumed 175 g or more, while 
40% did not meet this recommendation.  However, the recommended carbohydrate intake 
for women with GDM is 40-45%.  Carbohydrate is the primary source of energy for the 
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brain and is a source of kcals to help maintain body weight and to gain the appropriate 
amount of weight during pregnancy (National Academy of Sciences, 2002). 
Fiber Content 
Fiber content of diet ranged from 3 g to 30 g per day with a total mean value of 14 
g.  Based on recommendations from the Food and Nutrition Board, it is recommended 
that pregnant women consume 28 g of fiber per day (National Academy of Sciences, 
2002).  Therefore the majority of women in this study did not obtain the recommended 
amount of fiber.  Fiber is important during pregnancy to help improve lactation, reduce 
the risk of coronary heart disease, and assist in maintaining normal blood glucose levels 
as well as reducing constipation and hemorrhoids (National Academy of Sciences, 2002).   
Protein Content 
 Protein content of diet ranged from 34 g to 146 g per day with a total mean value 
of 82 g per day.  The current recommendation of grams of protein per day is 10 g above 
the Recommended Dietary Allowances (RDA) of 0.8g/kg of Desired Body Weight 
(DBW).  The current consumption recommendation for the US population for protein is 
10-35% of total kcal or 71 g per day (National Academy of Sciences, 2002).  Based on 
this finding, 64% met protein consumption recommendations, while 36% did not meet 
criteria.  The mean protein consumption as a percent of total kcals was 20% in this study, 
which is in line with the current recommendations for women with GDM.  Protein 
consumption is important because it serves as the major structural component of all cells 
in the body and functions as enzymes in membranes as transport carriers, and as some 
hormones (National Academy of Sciences, 2002).  Research has shown that blood 
glucose levels do not increase after protein ingestion, thus protein is often added to 
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increase calories without affecting blood glucose levels (American Dietetic Association, 
2001). 
Fat Content 
Fat content of the diet ranged from 22 g to 138 g per day with a total mean value 
of 65 g per day.  The current recommendation for fat intake is 20-35% of total calories 
during pregnancy (National Academy of Sciences, 2002).  The mean intake of fat as a 
percent of total calories was 35% in this study.  Based on the findings, 56% of the women 
did not meet the recommended intake, while 44% met criteria.  Fat consumption is 
important because it serves as an energy source and when found in foods, is a source of 
omega 6 and omega 3 polyunsaturated fatty acids (National Academy of Sciences, 2002).  
Its presence in the diet increases absorption of fat-soluble vitamins and precursors such as 
vitamin A and provitamin A carotenoids (National Academy of Sciences, 2002).  The 
increase in fat in this study is due to a decrease in carbohydrate intake and increased 
protein intake, which inherently adds fat (American Dietetic Association, 2001).  
Adequate fat intake is needed during pregnancy to provide essential fatty acids needed 
for fetal brain development (American Dietetic Association, 2001).  Because GDM is a 
short-term condition, the total amount of fat is not designed for long-term chronic disease 
prevention (American Dietetic Association, 2001). However, large amounts of fat 
consumption should be avoided to prevent excessive weight gain, which in turn can result 
in further insulin resistance (American Dietetic Association, 2001).   
Saturated Fat Content 
 Saturated fat content of diet ranged from 6 g to 49 g per day with a total mean 
value of 22 g or 12% per day.  The current recommendations for saturated fat intake 
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indicate that less than one third of the fat calories each day should come from saturated 
fat and less than one third from polyunsaturated fats; the balance should come from 
monounsaturated fats (American Dietetic Association, 2001).  Saturated fat has no 
required role in the body other than as an energy source; the body can synthesize its need 
for saturated fatty acids and cholesterol from other sources (National Academy of 
Sciences, 2002). 
Regression Analysis 
 Based upon data obtained from the regression analysis, pregnancy weight before 
delivery negatively correlated to blood glucose at breakfast.  Whereas a second 
regression analysis showed that carbohydrate intake at breakfast also negatively 
correlated with pregnancy weight before delivery.  It appears that pregnant women 
diagnosed with GDM, in this study, who had a lower pregnancy weight consumed more 
grams of carbohydrate at breakfast resulting in an increase in blood glucose level. 
Conversely pregnant women diagnosed with GDM with a higher weight consumed less 
grams of carbohydrate at breakfast, resulting in lower blood glucose levels.   The 
negative correlation of carbohydrate at breakfast to body weight and the negative 
correlation of body weight to blood glucose 1 hour after breakfast supports the current 
practice of limiting carbohydrate at the breakfast meal for women with GDM. 
 The final regression analysis showed that protein negatively correlated with blood 
glucose levels 1 hour after breakfast.   This appears to be a result of higher protein 
consumption and lower blood glucose levels, which shows that the participants in the 
study followed the basic guidelines of consuming more protein at breakfast to help keep 
blood glucose at tight control.   
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The mean blood glucose levels 1 hour after breakfast, lunch, and supper were 107, 
109, and 109, respectively.   This is because the participants of the study followed the 
current recommended diet set by the American Dietetic Association and the International 
Diabetes Center.   The participants were also seen by Registered Dietitians throughout the 
third trimester of their pregnancy that assisted the women with dietary compliance and 
with tight control of blood glucose levels.  These practices allowed for tight control of 
blood glucose, which is the goal of current practice. 
Recommendations 
 The objective of this study was to determine if consumption of carbohydrate, 
protein, fat, saturated fat, and fiber affect blood glucose in pregnant women diagnosed 
with Gestational Diabetes Mellitus.  Through the dietary counseling by Registered 
Dietitians and their scrutiny of blood glucose records during pregnancy, few of the 
pregnant women demonstrated blood glucoses values out of normal range.  This reflects 
that dietitians are vital to success of these pregnancies.  Unfortunately, in order to achieve 
the above objective, blood glucose would need to be out of normal range to correlate the 
macronutrients.  This is bad news.  The good news is that follow up by dietitians does 
help pregnant women maintain tight control of their blood glucose, which could result in 
better pregnancy outcomes. 
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